Nivalis Therapeutics (NVLS) Balance Sheet

Click line-items for a historical chart and %

Current assets:
Cash and cash equivalents	343.97M
Short-term investments	670M
Accounts receivable, net	226.76M
Inventories	225.84M
Deferred tax assets, net	36.1M
Other current assets	51.36M
Total current assets	1.55B
Property and equipment, net of accumulated depreciation of $581,945 in 2011 and $570,083 in 2010	206.47M
Non-current restricted cash and cash equivalents	122.31M
Long-term investments	46.47M
Goodwill	125.14M
Other non-current assets	20.49M
Total assets	2.07B
Current liabilities:
Accounts payable and accrued liabilities	87.38M
Accrued payroll and related expenses	39.2M
Accrued warranty	29.61M
Other current liabilities	69.55M
Income taxes payable	6.36M
Deferred profit	12.93M
Total current liabilities	518.1M
Senior convertible notes	0
Other long-term debt obligations	106.05M
Long-term income taxes payable	66.42M
Long-term deferred tax liabilities, net	118.86M
Other non-current liabilities	37.34M
Total liabilities	846.77M
Commitments and contingencies (Note 10)
Shareholders' equity:
Common stock	949.24M
Retained earnings (accumulated deficit)	-147.44M
Accumulated other comprehensive income (loss)	-577K
Total shareholders' equity	801.22M
Total liabilities and shareholders' equity	2.07B

Entities mentioned with NVLS